Progress of epigenetic study on nasopharyngeal carcinoma

Progress in Biochemistry and Biophysics

Volumn 34, Issue 7, 2007, Pages 673-681

  Liu, Hua Ying ^a   Peng, Shu Ping ^a   Zhou, Ming ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chromatin remodeling; DNA methylation; Epigenetic molecular marker; Epigenetics; Genetic regulation by non coding RNAs; Histone modification; Nasopharyngeal carcinoma

Indexed keywords

EID: 35348952685     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Esteller M. The necessity of a human epigenome project. Carcinogenesis, 2006, 27 (6) 1121-1125
2. Garber K. Momentum building for human epigenome project. J Natl Cancer Inst, 2006, 98 (2): 84-86
3. Rauscher F III. It is time for a human epigenome project. Cancer Res, 2005, 65 (24): 11229
4. Jones P A, Martienssen R. A blueprint for a human epigenome project: the AACR human epigenome workshop. Cancer Res, 2005, 65 (24): 11241-11246
5. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev, 2002, 16 (1): 6-21
6. Takai D, Jones P A. Comprehensive analysis of CpG islands in Human chromosomes 21 and 22. Proc Natl Acad Sci USA, 2002, 99 (6): 3740-3745
7. Jones P A, Laird P W. Cancer epigenetics comes of age. Nature Genet, 1999, 21 (2): 163-167
8. Feinberg A P, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 1983, 301 (5895): 89-92
9. Feinberg A P, Gehrke C W, Kuo K C, et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res, 1988, 48 (5): 1159-1161
10. Baylin S B, Herman J G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet, 2000, 16 (4): 168-174
11. Herman J G, Baylin S B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med, 2003, 349 (21): 2042-2054
12. Fraga M F, Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle, 2005, 4 (10): 1377-1381
13. Wei W I, Sham J S. Nasopharyngeal carcinoma. Lancet, 2005, 365 (9476): 2041-2054
14. Lo K W, To K F, Huang D P. Focus on nasopharyngeal carcinoma. Cancer Cell, 2004, 5 (5): 423-428
15. Chan A T C, Teo P M L, Johnson P J. Nasopharyngeal carcinoma. Ann Oncol, 2002, 13 (7): 1007-1015
16. Yu M C, Yuan J M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 2002, 12: 421-429
17. Feil R. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat Res, 2006, 600 (1-2): 46-57
18. Peng D, Ren C P, Yi H M, et al. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin (Shanghai), 2006, 38 (5): 349-355
19. Seng T J, Low J S, Li H, et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene, 2007, 26: 934-944
20. Ying J, Li H, Seng T J, et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene. 2006, 25 (7): 1070-1080
21. Pan Z G, Kashuba V I, Liu X Q, et al. High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther, 2005, 4 (10): 1116-1122
22. Chow L S, Lo K W, Kwong J, et al. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer, 2004, 109 (6): 839-847
23. Zhou L, Jiang W, Ren C, et al. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia, 2005, 7 (9): 809-815
24. Qiu G H, Tan L K, Loh K S, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene. 2004, 23 (27): 4793-4806
25. Kwong J, Lo K W, Chow L S, et al. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia, 2005, 7 (1): 67-74
26. Kwong J, Lo K W, Chow L S, et al. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int J Cancer. 2005, 113 (3): 386-392
27. Thompson M P, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res, 2004, 10 (3): 803-821
28. Tsai C N, Tsai C L, Tse K P, et al. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA, 2002, 99 (15): 10084-10089
29. Li H, Minarovits J. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv Cancer Res, 2003, 89: 133-156
30. Lung H L, Cheng Y, Kumaran M K, et al. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer, 2004, 112 (4): 628-635
31. Hui A B, Lo K W, Kwong J, et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinog, 2003, 38 (4): 170-178
32. Xiang Y N, Zhang W Y. The clinical significance of p16 protein non-expression and p16 gene inactivation by deletions and hypermethylation in nasopharyngeal carcinoma. Chinese Journal of Pathology, 2005, 34 (6): 358-361
33. Cheung H W, Ching Y P, Nicholls J M, et al. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation. Mol Carcinog, 2005, 43 (4): 237-245
34. Liu X Q, Chen H K, Zhang X S, et al. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer, 2003, 106 (1): 60-65
35. Strahl B D, Allis C D. The language of covalent histone modifications. Nature, 2000, 403 (6765): 41-45
36. Turner B M. Cellular memory and the histone code. Cell, 2002, 111 (3): 285-291
37. Luger K, Mader A W, Richmond R K, et al. Crystal structure of the nucleosome core particle at 2.8 Åx resolution. Nature, 1997, 389 (6648): 251-260
38. Cong P, Jie Z, Ying L H, et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J Cell Biochem, 2006, 97 (4): 882-892
39. Zhou J, Ma J, Zhang B C, et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol, 2004, 200 (1): 89-98
40. Zhang A, Yeung P L, Li C W, et al. Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators. J Biol Chem, 2004, 279 (32): 33799-33805
41. Nishikawa J, Kis L L, Liu A, et al. Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. Virus Genes, 2004, 28 (1): 121-128
42. Lusser A, Kadonaga J T. Chromatin remodeling by ATP-dependent molecular machines. Bioessays, 2003, 25 (12): 1192-1200
43. Turner B M. Decoding the nucleosome. Cell, 1993, 75 (1): 5-8
44. Khochbin S. Histone H1 diversity: bridging regulatory signals to linker histone function. Gene, 2001, 271 (1): 1-12
45. Mattick J S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep, 2001, 2 (11): 986-991
46. Mattick J S. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays, 2003, 25 (10): 930-939
47. Yang M, Li Y, Padgett R W. MicroRNAs: Small regulators with a big impact. Cytokine Growth Factor Rev, 2005, 16 (4-5): 387-393
48. Yelin R, Dahary D, Sorek R, et al. Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol, 2003, 21 (4): 379-386
49. Mattick J S. RNA regulation: a new genetics?. Nat Rev Genet, 2004, 5 (4): 316-323
50. Calin G A, Croce C M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res, 2006, 66 (15): 7390-7394
51. Kiss A M, Jady B E, Bertrand E, et al. Human box H/ACA pseudouridylation guide RNA machinery. Mol Cell Biol, 2004, 24 (13): 5797-5807
52. Esquela-Kerscher A, Slack F J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 2006, 6 (4): 259-269
53. Calin G A, Sevignani C, Dumitru C D, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA, 2004, 101 (9): 2999-3004
54. Calin G A, Dumitru C D, Shimizu M, et al. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 2002, 99 (24): 15524-15529
55. Medicine Stanford, Calif He L, Thomson J M, et al. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435: 828-833
56. Cimmino A, Calin G A, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA, 2005, 102 (39): 13944-13949